452 Drug Delivery I: Biologics


Description:
This session deals with the latest advances in drug delivery methods and related technologies. Specific topics of interest include (not limited to) novel drug carriers and drug delivery devices, new drug release/activation strategies, cell response to drugs via these strategies, and related material design or in-depth characterization of cell signaling responses. Both computational and experimental approaches to drug delivery are appropriate.

Sponsor:
Engineering Fundamentals in Life Science
Co-Sponsor(s):
Biomaterials (08B)


Co-chairs:
Rachel A. Letteri
Postdoc
Texas A&M University
Chemistry
College Station, TX
01003
Email: rachel.letteri@tamu.edu

Lorraine Leon
Assistant Professor
University of Central Florida
Materials Science & Engineering
Orlando, FL
60637
Phone Number: 407-823-5378
Email: lorraine.leon@ucf.edu


Papers:
452a
Polymersomes Deliver Active Enzyme to the Brains of Felines As Treatment of Neurodegeneration
Jessica Kelly, Clemson University; Amanda Gross, Auburn University; Doug Martin, Auburn University; Mark E. Byrne, Rowan University
452b
Poly(N-Isopropylacrylamide):Collagen Hydrogels for Tunable Syneresis and Drug Delivery
Katarina DiLillo, Lafayette College; Christopher Anderson, Lafayette College
452c
Erythrocytes As Carriers of Immunoglobulin Based Therapeutic Drugs
Weihang Ji, Carnegie Mellon University; Richard Koepsel, Carnegie Mellon University; Jill Andersen, Carnegie Mellon University; Sheiliza Carmali, Carnegie Mellon University; Alan Russell, Carnegie Mellon University
452d
Mixed Posh Inhibitor Micelles As a Novel Leukemia Therapeutic Modality
Josiah Smith, University of Missouri; Leah Cardwell, University of Missouri; David Porciani, University of Missouri; Julie A. Nguyen, University of Missouri; Andrea Nolla, University of Missouri; Fabio Gallazzi, University of Missouri; Donald Burke, University of Missouri; Mark Daniels, University of Missouri; Bret Ulery, University of Missouri
452e
Transcriptome Analysis of the Host Cell Response to Non-Viral Gene Therapy
Matthew Tucker, Villanova University; Jacob Elmer, Villanova University
452f
Investigating the Effect of Cross-Linker Branching and Conjugation Site on the Stability and Efficacy of Antibody-Drug Conjugates
Joshua A. Walker, Cornell University; Francis Ledesma, Cornell University; Michelle R. Sorkin, Cornell University; Sneha R. Kabaria, Cornell University; Christopher A. Alabi, Cornell University
452g
Invited Speaker: Lipid Nanoparticle Formulations for the Synergistic Co-Delivery of siRNA and mRNA
Kathryn A. Whitehead, Carnegie Mellon University
Abstract Submissions Closed
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>